Abstract
Bupropion is an antidepressant drug also used as a smoking cessation aid, which inhibits norepinephrine and dopamine re-uptake. Given its pharmacological properties, it has been associated with reports on psychosis and acute delirious episodes. Case We report the case of a patient with schizoaffective disorder who developed two psychotic episodes respectively after a four and a two-day administration of sustained-release (SR) bupropion at a dose of 150 mg/day. To our knowledge, this is the first reported case of involuntary rechallenge with bupropion SR during a smoking cessation program. Conclusion There is a serious risk of incorrectly identifying bupropion as only a therapy for nicotine withdrawal without taking the precaution of exploring possible psychiatric co-morbidity with addiction. Our case illustrates the problem.
References
Golden RN, James SP, Sherer MA, Rudorfer MV, Sack DA, Potter WZ. Psychoses associated with bupropion treatment. Am J Psychiatry. 1985;142(12):1459–62.
Johnston JA, Lineberry CG, Frieden CS. Prevalence of psychosis, delusions, and hallucinations in clinical trials with bupropion. Am J Psychiatry. 1986;143(9):1192–3.
Golden RN. Diethylpropion, bupropion, and psychoses. Br J Psychiatry. 1988;153:265–6. doi:10.1192/bjp.153.2.265.
Ames D, Wirshing WC, Szuba MP. Organic mental disorders associated with bupropion in three patients. J Clin Psychiatry. 1992;53(2):53–5.
Howard WT, Warnock JK. Bupropion-induced psychosis. Am J Psychiatry. 1999;156(12):2017–8.
Neumann M, Livak V, Paul HW, Laux G. Acute psychosis after administration of bupropion hydrochloride (Zyban). Pharmacopsychiatry. 2002;35(6):247–8. doi:10.1055/s-2002-36393.
Wang TS, Shiah IS, Yeh CB, Chang CC. Acute psychosis following sustained release bupropion overdose. Prog Neuropsychopharmacol Biol Psychiatry. 2005;29(1):149–51. doi:10.1016/j.pnpbp.2004.10.003.
Hahn M, Hajek T, Alda M, Gorman JM. Psychosis induced by low-dose bupropion: sensitization of dopaminergic system by past cocaine abuse? J Psychiatr Pract. 2007;13(5):336–8. doi:10.1097/01.pra.0000290673.32978.e8.
Dager SR, Heritch AJ. A case of bupropion-associated delirium. J Clin Psychiatry. 1990;51(7):307–8.
Liberzon I, Dequardo JR, Silk KR. Bupropion and delirium. Am J Psychiatry. 1990;147(12):1689–90.
Van Putten T, Shaffer I. Delirium associated with bupropion. J Clin Psychopharmacol. 1990;10(3):234. doi:10.1097/00004714-199006000-00028.
Chan CH, Liu HC, Huang MC. Delirium associated with concomitant use of low-dose bupropion sustained release and fluoxetine. J Clin Psychopharmacol. 2006;26(6):677–9. doi:10.1097/01.jcp.0000246210.18777.c2.
Bailey J, Waters S. Acute psychosis after bupropion treatment in a healthy 28-year-old woman. J Am Board Fam Med. 2008;21(3):244–5. doi:10.3122/jabfm.2008.03.070236.
Settle EC. Bupropion sustained release: side effect profile. J Clin Psychiatry. 1998;59(Suppl 4):32–6.
Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239–45.
Acknowledgements
The authors want to express their gratitude to the translators, Mr Jean-Yves Bart and Mr Jesse David Tatum, for revising the text.
Conflicts of interest
All the authors of this article attest that there was no potential conflict of interest that could have influenced this work.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Javelot, H., Baratta, A., Weiner, L. et al. Two acute psychotic episodes after administration of bupropion: a case of involuntary rechallenge. Pharm World Sci 31, 238–240 (2009). https://doi.org/10.1007/s11096-008-9272-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11096-008-9272-x